Why The FDA — And Investors — Just Slammed Hims Stock
- Posted on September 16, 2025
- By Google News
- 1 Views
Why The FDA — And Investors — Just Slammed Hims Stock
The company is best-known for its compounded weight-loss drugs. But those could be in trouble.
